Protocol
PEMF (Pulsed Electromagnetic Field) for osteoarthritis symptoms
Sham-controlled trials of pulsed electromagnetic field devices for osteoarthritis give mixed pooled results on self-reported pain and function: some meta-analyses A study that pools the numbers from several trials into one combined estimate. find short-term benefit, others none at one month, with high risk of bias and wide variation in device settings.
Grade C: human trials exist, but they are small, mixed or not yet repeated. This is not a finding that it does not work. How to read a grade →
Compare this record with another, side by side →
How this letter has changedLatest: October 2026 · Corrected.
The description graded a consumer longevity application on an osteoarthritis meta-analysis and called fracture non-union evidence solid. No randomized trial of PEMF on a longevity, aging or hard outcome exists, and the Cochrane review of non-union (Griffin et al., 2011; PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 21491410) found the pooled effect not significant, with a 2024 update (Picelli et al., PMID 39387850) not supporting PEMF for acute fractures. Added beside Wu 2018 (PMID 30552258): the null pain results of Chen et al. (2019; PMID 31583420) and Chang et al. (2026; PMID 42075549). The not-replicated flag, wrong for a 12-trial meta-analysis, is replaced; the evidence is mixed, not unreplicated. The name now states the graded use. C unchanged. Applied the written grade definition under the editor's standing instruction of October 2026 (Arnold Sandlow, D.C.).PMID 21491410 PMID 30552258 PMID 31583420 PMID 39387850 PMID 42075549
Every change to a letter on this site is dated and published. The full evidence log →
PEMF uses pulsing magnetic fields applied to the body. It has been tested for arthritis of the knee and hand. Reviews of studies against a fake device disagree. One found less pain and better movement, one found better movement but no less pain, and the newest found no clear benefit. So the results are mixed.
Sham-controlled trials of pulsed electromagnetic field devices for osteoarthritis give mixed pooled results on self-reported pain and function: some meta-analyses find short-term benefit, others none at one month, with high risk of bias and wide variation in device settings. No randomized trial has tested PEMF on any longevity, aging or hard outcome in healthy adults. Devices hold FDA clearance for fracture non-union, but the Cochrane review found the pooled union effect not significant and a 2024 review does not support PEMF for acute fracture healing.
Why this gradeGrade C, small or unreplicated trials. The reasoning, and what the grade does not cover.
Grade C on osteoarthritis pain and function. Sham-controlled meta-analyses disagree: Wu et al. (2018; PMID 30552258) pooled pain and function benefit in knee and hand osteoarthritis, Chen et al. (2019; PMID 31583420) found function improved but no pain or stiffness benefit, and Chang et al. (2026; PMID 42075549) found no VAS pain or total WOMAC benefit at one month and no change in objective function, with high risk of bias. Outcomes are self-reported and device settings vary widely, so mixed small trials are C.
WHAT THIS GRADE DOES NOT COVERconsumer longevity or healthy-aging use, where no randomized trial exists; fracture non-union, where devices hold FDA clearance but the Cochrane review (PMID 21491410) found the pooled effect not significant and a 2024 review (PMID 39387850) does not support PEMF for acute fractures; cervical osteoarthritis, where the pooled result was null; and bone density, which no cited trial measured.
A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →
The evidence, in fullFive papers, each linked to its PubMed record.
Wu et al. (BMJ Open, 2018; PMID 30552258): meta-analysis of 12 sham-controlled trials; pain and function improved in knee and hand osteoarthritis, not in cervical osteoarthritis; self-reported outcomes, mixed quality. Chen et al. (J Rehabil Med, 2019; PMID 31583420): 8 sham-controlled knee osteoarthritis trials, 421 patients; physical function score improved, no advantage on WOMAC pain, VAS pain or stiffness. Chang et al. (Medicina, 2026; PMID 42075549): 9 trials, 457 patients; no significant improvement in VAS pain or total WOMAC at one month, objective function unchanged, overall risk of bias high. Fracture healing: Griffin et al. (Cochrane, 2011; PMID 21491410), 4 sham-controlled trials in delayed union or non-union, 125 people; pooled union risk ratio 1.96 (95% CI 0.86 to 4.48), not significant, evidence judged inconclusive. Picelli et al. (Eur J Phys Rehabil Med, 2024; PMID 39387850): systematic review A review that searches for every study on a question using a method set in advance, then assesses them together. update, 3 trials in acute fractures, none finding an effect on bone healing. Grade C: mixed pooled self-reported results in osteoarthritis.
For osteoarthritis, VAS pain and WOMAC scores at baseline and 4 weeks, with the knowledge that pooled benefits faded by one month in the newest meta-analysis. Device parameters (frequency, intensity, treatment area, session duration) at every use: PEMF dose varies enormously between devices and the published evidence is specific to frequency and waveform. Bone density is not a graded endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. on this record.
Evidence notes: meta-analysis, randomized trial
Endpoint graded: Self-reported osteoarthritis pain and function (self_report)
Last reviewed: July 2026
Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.
Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy
© Evidence Based Longevity, Inc.. All rights reserved
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →